Biblio Discovery — Demo Discovery Service

22 results for "Flora Sam"

Showing 1–20 · 0.57 seconds · RSS

  1. Journal Article

    Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales

    Albin Oh; Ross Okazaki; Flora Sam et al.

    Frontiers in Cardiovascular Medicine, Vol. 6 · 2019 · English · DOAJ Scopus

    Heart failure with preserved ejection fraction (HFpEF) is characterized by signs and symptoms of heart failure in the presence of a normal left ventricular ejection fraction. Although it accounts for up to 50% of all clinical presentations of heart failure, there are no evidence-based therapies for…

  2. Journal Article

    Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor

    Eric E. Essick; Flora Sam

    International Journal of Hypertension, Vol. 2011 · 2011 · English · DOAJ Scopus

    Obesity and hypertension, major risk factors for the metabolic syndrome, render individuals susceptible to an increased risk of cardiovascular complications, such as adverse cardiac remodeling and heart failure. There has been much investigation into the role that an increase in the…

  3. Journal Article

    Adiponectin in Cardiovascular Inflammation and Obesity

    Tamar R. Aprahamian; Flora Sam

    International Journal of Inflammation, Vol. 2011 · 2011 · English · DOAJ Scopus

    Inflammation is widely known to play a key role in the development and progression of cardiovascular diseases. It is becoming increasingly evident that obesity is linked to many proinflammatory and obesity-associated cardiovascular conditions (e.g., metabolic syndrome, acute coronary syndrome, and…

  4. Journal Article

    Reply

    Maria Valero-Muñoz, PhD; Flora Sam, MD

    JACC: Basic to Translational Science, Vol. 3 No. 1 · 2018 · English · DOAJ Scopus

  5. Journal Article

    Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction

    Eng Leng Saw; Louis Dominic Werner; Payman Zamani et al.

    Frontiers in Cardiovascular Medicine, Vol. 9 · 2022 · English · DOAJ Scopus

    BackgroundSkeletal muscle (SkM) phenotypic switching is associated with exercise intolerance in heart failure with preserved ejection fraction (HFpEF). Patients with HFpEF have decreased type-1 oxidative fibers and mitochondrial dysfunction, indicative of impaired oxidative capacity. The SAUNA…

  6. Journal Article

    Murine Models of Heart Failure With Preserved Ejection Fraction

    Maria Valero-Muñoz, PhD; Warren Backman, MD; Flora Sam, MD

    JACC: Basic to Translational Science, Vol. 2 No. 6 · 2017 · English · DOAJ Scopus

    Heart failure with preserved ejection fraction (HFpEF) is characterized by signs and symptoms of heart failure in the presence of a normal left ventricular ejection fraction. Despite accounting for up to 50% of all clinical presentations of heart failure, the mechanisms implicated in HFpEF are…

  7. Journal Article

    Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes

    Keith C. Ferdinand; Julia Dunn; Claudia Nicolay et al.

    Cardiovascular Diabetology, Vol. 22 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Patients with type 2 diabetes (T2D) treated with glucagon-like peptide-1 receptor agonists may experience reductions in weight and blood pressure. The primary objective of the current study was to determine the weight-dependent and weight-independent effects of ~ 6 months…

  8. Journal Article Full text

    Adiponectin Modulates Oxidative Stress-Induced Autophagy in Cardiomyocytes

    Eric E. Essick; Richard M. Wilson; David R. Pimentel et al.

    PLoS ONE, Vol. 8 No. 7 · 2013 · English · PLOS Scopus

    Diastolic heart failure (HF) i.e., “HF with preserved ejection fraction” (HF-preserved EF) accounts for up to 50% of all HF presentations; however there have been no therapeutic advances. This stems in part from an incomplete understanding about HF-preserved EF. Hypertension is the major cause of…

    Also available at: DOAJ

  9. Journal Article

    Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications

    Fatima El-Adili; Justin K. Lui; Mortada Najem et al.

    Arthritis Research & Therapy, Vol. 24 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Objective To evaluate the levels of periostin in patients with systemic sclerosis (SSc) and their association with features of systemic sclerosis. Methods The levels of periostin were assessed in the serum of 106 SSc patients and 22 healthy controls and by immunofluorescence staining in…

  10. Journal Article

    White Adipose Tissue in Obesity-Associated HFpEF

    María Valero-Muñoz, PhD; Eng Leng Saw, PhD; Hannah Cooper, BA et al.

    JACC: Basic to Translational Science, Vol. 10 No. 8 · 2025 · English · DOAJ Scopus

    Summary: Obesity and hypertension are prevalent comorbidities in heart failure with preserved ejection fraction (HFpEF). Increased adiposity is implicated in its pathophysiology. We investigated changes in white adipose tissue (WAT) in obesity-associated HFpEF utilizing patient samples and a murine…

  11. Journal Article

    Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study

    Sheraz A. Butt; Jørgen L. Jeppesen; Christian Torp‐Pedersen et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 8 No. 17 · 2019 · English · DOAJ Scopus

    Background Cardiovascular involvement in systemic sclerosis (SSc) comprises a wide range of manifestations with prevalence and incidence that remain uncertain. Methods and Results In the Danish administrative registries between 1995 and 2015, all patients aged ≥18 years with a first diagnosis of…

  12. Journal Article

    Assessing left atrial systolic contribution via pressure-volume loops in murine HFpEF

    Hana E. Baker; Tatyana Belle-Oladeji; Marialuisa Andreasson et al.

    Frontiers in Cardiovascular Medicine, Vol. 13 · 2026 · English · DOAJ Scopus

    Left atrial (LA) myopathy plays a critical role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). This study aimed to evaluate LA function in a murine model of hypertension-induced HFpEF, with and without obesity, by analyzing left ventricular (LV) pressure signals…

  13. Journal Article

    Metabolic dysregulation in the heart in obesity-associated HFpEF

    Maria Valero-Muñoz; Hannah L. Cooper; Shanpeng Li et al.

    Frontiers in Cardiovascular Medicine, Vol. 12 · 2025 · English · DOAJ Scopus

    BackgroundObesity and hypertension are among the most prevalent comorbidities in heart failure with preserved ejection fraction (HFpEF). In addition to its relationship with hypertension in HFpEF, obesity is also strongly associated with insulin resistance (IR) and type 2 diabetes (T2D). However…

  14. Journal Article

    Association of Long‐Term Body Mass Index Variability With the Development of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction Across Patterns of Weight Change

    Zeshui Yu; Yuqing Chen; Oshin Miranda et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 18 · 2025 · English · DOAJ Scopus

    Background Body mass index (BMI) variability is a risk factor for various adverse cardiovascular outcomes. However, the specific associations between BMI variability and the risk of developing heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction…

  15. Journal Article

    Molecular insights in HIV-associated cardiac dysfunction

    María Valero-Muñoz; Eng Leng Saw; David R. Pimentel et al.

    Communications Medicine, Vol. 6 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Antiretroviral therapy (ART) in human immunodeficiency virus (HIV) markedly improved life expectancy in persons living with HIV (PLWH), but cardiac disease has emerged as the leading cause of death in this population. The prevalence of impaired diastolic function and heart…

  16. Journal Article

    Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)

    María Valero-Muñoz; Eng Leng Saw; Ryan M. Hekman et al.

    Frontiers in Cardiovascular Medicine, Vol. 9 · 2022 · English · DOAJ Scopus

    Although the prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, evidence-based therapies for HFpEF remain limited, likely due to an incomplete understanding of this disease. This study sought to identify the cardiac-specific features of protein and phosphoprotein…

  17. Journal Article

    Research Priorities for Heart Failure With Preserved Ejection Fraction

    Sanjiv Jayendra Shah; Barry A. Borlaug; Dalane W. Kitzman et al.

    Circulation · 2020 · English · OpenAlex Scopus

    Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is rising in prevalence, is associated with high morbidity and mortality and is considered to be the greatest unmet need in cardiovascular medicine today because of a general lack of effective treatments. To…